UK financial regulator warns firms off D&I vagueness

Listed financial firms in the UK have been warned by regulator the Financial Conduct Authority (FCA) that the first annual reports to cover new diversity and inclusion (D&I) reporting requirements must hit D&I targets or contain “clear and meaningful explanation’ of why targets were missed.

EU pharma law reform faces further delay

Pharmaceutical businesses would rather EU policymakers get legislative reforms right than rush through imperfect changes that will have a long-term negative impact on industry, an expert in life sciences regulation has said.

Hysteria over Aukus nuclear-powered submarines is off the mark

Some have misunderstood the plan as involving nuclear-armed submarines; others that it amounts to nuclear proliferation. The greater concerns are the eye-watering costs to the Australian taxpayer, the unhelpful political messaging from the commentariat and the significant environmental considerations.